Bank of New York Mellon »

Outlook Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2025-03-31 $33k 27k 1.22
2024-12-31 $56k 30k 1.89
2024-09-30 $110k 21k 5.34
2024-06-30 $150k 20k 7.38
2024-03-31 $239k 20k 11.94